Skip to main content
. Author manuscript; available in PMC: 2018 Aug 1.
Published in final edited form as: J Clin Psychopharmacol. 2017 Aug;37(4):394–400. doi: 10.1097/JCP.0000000000000720

Table 2. SANS Total Score by Treatment and Week.

Galantamine Oxytocin Placebo
Week N Mean S.D. N Mean S.D. N Mean S.D.
0 19 36.63 10.97 15 33.23 6.91 19 36.63 10.61
2 19 35.22 10.26 15 30.07 6.93 19 35.05 10.52
4 18 34.06 10.64 15 31.27 7.53 18 34.22 9.61
6 18 33.22 11.27 15 31.40 6.85 17 33.47 8.47
Δ2* 19 -1.41 3.32 15 -3.17 4.20 19 -1.58 4.84
Δ4* 18 -1.69 3.46 15 -1.97 4.48 18 -1.47 5.64
Δ6* 18 -2.53 4.34 15 -1.83 3.74 17 -1.00 4.41
*

Δx= change from week 0 at week x.

SANS total score comparison at week 6 (post hoc tests from MM-ANCOVA):
  • Oxytocin versus placebo: estimated mean difference in total scores ± s.e.: -1.02 ± 1.55; t= -0.66; df=46.9; p=0.51; Cohen's d = -0.10.
  • Galantamine versus placebo: estimated mean difference in total scores ± s.e.: -1.45 ± 1.39; t= -1.04; df= 46.9; p=0.30; Cohen's d= -0.15.